While studies in the meta-analysis described above excluded patients with a history of gallstones, clinical outcomes showed that higher doses and longer periods of use with GLP1-RAs have been associated with the greatest risk
Switching between GLP-1 receptor agonists in clinical practice: expert consensus and practical guidance
But there are early signs that GLP-1s can make a difference at the population level
Water/Aqua/Eau, 1,2-Hexanediol, Phenoxyethanol, Avena Sativa (Oat) Kernel Extract, Lactic Acid, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Propanediol, Sodium Hydroxide, Silica Cetyl Silylate, Sodium Polyacrylate, Citric Acid, Allantoin, Caffeine, Dimethyl MEA, Silica, Butylene Glycol, Disodium EDTA, Gentiana Lutea Root Extract, Caprylyl Glycol, Sodium Hyaluronate, Ethylhexylglycerin, S-Palmitoylglutathione, Tetrapeptide-1, Potassium Sorbate, Acetic Acid, Acetyl Hexapeptide-8, Arginine/Lysine Polypeptide, Iron Oxides (CI 77491), Titanium Dioxide (CI 77891) For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption